| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcc6388dcf833a83b4099d3a2ee7cee9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a464d3fcc2df42e1308fea34367f5104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a9a4b63d683a931087e90282256a154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a8332b42c844c7bdf7690d3bd7af13d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
| filingDate |
2009-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b4cf5235a236f2d98b5c78abdf68e21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513cd5843ac21233e9d91015fdf57948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_211758749bbe49e5acd306ab053e87cb |
| publicationDate |
2009-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009138489-A1 |
| titleOfInvention |
Plasmacytoid dendritic cell line used in active or adoptive cell therapy |
| abstract |
The present invention relates to a method for inducing and amplifying specific effectors, which comprises obtaining pulsed plasmacytoid dendritic cells (pDC) by incubation of a pDC line with at least one antigen, the pulsed pDC being subsequently irradiated and brought into contact with peripheral blood mononuclear cells (PBMC), and cultured or injected into an organism. The pulsed and irradiated pDC and the PBMC share at least one major histocompatibility complex (MHC) allele. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017103521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3087448-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018134356-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020083974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3045386-A1 |
| priorityDate |
2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |